Sebastian Wiberg Profile
Sebastian Wiberg

@scwib

Followers
104
Following
887
Media
1
Statuses
97

Joined September 2016
Don't wanna be here? Send us removal request.
@dk_DRG
Dansk Råd for Genoplivning
2 years
Nye tal fra Dansk Hjertestopregister viser, at hvis man overlever de første 30 dage efter et hjertestop uden for hospital, er der stor sandsynlighed for, at man også er i live ét år efter hjertestoppet. Læs rapporten her: https://t.co/v2Gxt8yo7C
0
2
6
@DrFDamico
Filippo D'Amico
2 years
1/9 “Low versus High Blood Pressure Targets in Critically Ill and Surgical Patients” 🧨 The meta-analysis that redefines how we interpret blood pressure ⁉️ What are the reasons behind this paradigm shift from 'higher is better'? https://t.co/0fPcY2cw8b
3
22
37
@laustemil
Laust Obling
2 years
🚑 Exciting STEROHCA results! 📊 Prehospital high-dose glucocorticoid treatment significantly reduces norepinephrine use in comatose OHCA patients (p = 0.02). 📈 Additionally, the glucocorticoid group exhibited higher MAP and lower VIS/MAP ratio. Link: https://t.co/HyTXIYKUAo
3
7
40
@scwib
Sebastian Wiberg
2 years
Great presentation by @laustemil 🏆
0
0
10
@TimBuchmanMDPhD
Timothy G. Buchman
2 years
@karimbrohi This is important for so many reasons. 1. We want to believe. 2. We cannot escape beliefs without rigorous trials. 3. Lessons learned from those trials will change care. 4. New hypotheses will emerge, and they will be championed. 5. (Go to “1”).
0
5
23
@dk_DRG
Dansk Råd for Genoplivning
3 years
Med støtte fra A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal vil DRG udvikle et undervisningskoncept til elever i 6.-8. klasse, som skal gøre det nemt for lærerne at undervise i livreddende førstehjælp og stroke. Læs mere her: https://t.co/11fA04vSTB
0
1
5
@RigsHeart
RigsHeart 🫀🚨
3 years
In this std @MartinM14175949 et al. investigated how the inflammatory response in #OHCA is modulated with tocilizumab💉 With this treatment, the authors found: 🔸increases for IL-5, IL-6 🔸decreases for neutrophils & monocytes 🔸reduced vasopressor requirements @ResusJournal
1
5
18
@RigsHeart
RigsHeart 🫀🚨
3 years
Just published! This #BOXtrial randomized #OHCA pts to device-based fever prevention🌡 for 36/72 hrs and found no different % of pts dying☠️ or having severe disability/coma😵 Presented at #ReSS22 by Prof. @CHassager👨‍⚕️
@NEJM
NEJM
3 years
In this trial involving patients after out-of-hospital cardiac arrest, fever prevention for 36 or 72 hours did not result in different percentages of patients dying or having severe disability or coma. #AHA22 https://t.co/Cx6x4RfqCE
0
1
16
@NEJM
NEJM
3 years
There is limited evidence to support the choice of specific blood-pressure targets for treating comatose survivors of out-of-hospital cardiac arrest. New research findings are summarized in a short video. https://t.co/rDK358A6AL
2
16
43
@dk_DRG
Dansk Råd for Genoplivning
3 years
Kom så, Peter! Og kom så, alle andre! Sammen kan vi nemlig oprette Hjertesikre Zoner og sørge for, at flere hver dag overlever hjertestop i Danmark. Læs mere på https://t.co/tuwDEwF9ip
0
4
11
@Rheum2improve
Laura Durcan
3 years
This is an awesome slide. @Lupusdoc
18
197
1K
@NEJM
NEJM
3 years
BOX BP: This randomized trial found no difference in the rate of death or severe disability/coma when patients following out-of-hospital cardiac arrest were managed with higher or lower blood pressure targets. #ESCCongress https://t.co/5qOMtiPSck
1
52
111
@HelleSoholm
Helle Søholm
3 years
Interesting manuscript covering the potential of eCPR in in-hospital cardiac arrest patients.
@EHJACVCEiC
EHJACVC Editor-in-Chief
3 years
Eligibility of #ECPR on in-hospital cardiac arrests in Sweden: a national registry study - eligibility low but estimated potential benefit if initiated within 60 minutes. #ECMO #ECLS https://t.co/qXA7m2kwdV
0
1
5
@dk_DRG
Dansk Råd for Genoplivning
3 years
DRGs nye nationale retningslinjer for førstehjælp og genoplivning til livreddere: https://t.co/Aepa1hw9SF Tak til @NiklasBreindahl, @scwib, Christian Maschmann, TrygFonden Kystlivredning, SafetyGroup og Nordsjællandske Livredningstjeneste for det store arbejde og faglig sparring
0
1
4
@CritCareReviews
Critical Care Reviews
3 years
90 day mortality the same between the two groups #CLASSICtrial ! #CCR22
1
6
23
@EMSwami
Anand Swaminathan MD MPH 🏳️‍🌈🇺🇦
4 years
Cochrane Rev: IV MgSO4 assoc w/ reduced hospitalization + length of stay in COPD exacerbation https://t.co/4iZaTTxLN3 ⬇️🏥: OR 0.45 NNT = 7 ⬇️🏥LOS: 2.7 days No benefit in reduction of NIV Nebulized Mg does not appear to carry same benefits
6
69
176
@PSMIDTDK
Poul SMIDT
4 years
Denne artikel er så klog, så begavet, at jeg må sove med den under hovedpuden, så den siver helt ind og aldrig glemmed. Tillige sjov, så nu venter vi kun på de røde ører i DR-byen// Satire, opmærksomhed og alt det 'Ellen imellem'
uniavisen.dk
Med det omdiskuterede program 'Ellen imellem' viser DR, at de går mere op i at tiltrække sig folks opmærksomhed end at bedrive public service. Det skriver professor i filosofi Vincent F. Hendricks.
2
14
116
@EHJACVCEiC
EHJACVC Editor-in-Chief
4 years
Targeted Temeprature Management - quo vadis? An expert educational review in #EHJACVC discusses the history, rationale and evidence for #TTM and provides a critical review of TTM2, research needs for the future and guidance for clinical practice https://t.co/kX7r7qIAcr
0
13
30
@drjohnm
John Mandrola, MD
4 years
Closing remark from this evenings journal club: “Clinicians can’t rely on anyone else for interpretation of evidence… It’s up to us to learn how to critically appraise studies.” (Perhaps this is in the running for the modern-day Hippocratic oath)
11
19
103